{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699996285530368.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/35095584"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/nri35095584.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/nri35095584"}},{"identifier":{"@type":"NAID","@value":"30014134187"}}],"dc:title":[{"@value":"Epstein-Barr virus: exploiting the immune system"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699996285530368","@type":"Researcher","foaf:name":[{"@value":"David A. Thorley-Lawson"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"14741733"},{"@type":"EISSN","@value":"14741741"}],"prism:publicationName":[{"@value":"Nature Reviews Immunology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2001-10","prism:volume":"1","prism:number":"1","prism:startingPage":"75","prism:endingPage":"82"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/nri35095584.pdf"},{"@id":"http://www.nature.com/articles/nri35095584"}],"createdAt":"2002-09-20","modifiedAt":"2023-05-19","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360283694891238528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705268481280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Modes of infection and oncogenesis by the Epstein–Barr virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617866445824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pathologically Relevant Mouse Models for Epstein–Barr Virus–Associated B Cell Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848655027475200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"B cells latently infected with murine gammaherpesvirus 68 (MHV‐68) are present in the mouse thymus–A step toward immune evasion?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848659542952320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bystander inhibition of humoral immune responses by Epstein–Barr virus LMP1"}]},{"@id":"https://cir.nii.ac.jp/crid/1363949023325501696","@type":"Article","resourceType":"レビュー論文(review article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Spectrum of Epstein-Barr virus-related diseases: a pictorial review"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205077667200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"持続性ウイルス感染症と発がん　２．　　ＥＢウイルス感染と発がん"},{"@language":"en","@value":"Epstein-Barr virus and oncogenesis"},{"@language":"ja-Kana","@value":"EB ウイルス カンセン ト ハツガン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680722881664","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Levels of DNA of CMV, EBV, and HHV-6 in HIV-positive Subjects"},{"@language":"ja","@value":"HIV感染者におけるCMV, EBV, HHV-6ウイルスDNA量の解析"},{"@language":"ja-Kana","@value":"HIV カンセンシャ ニ オケル CMV EBV HHV 6 ウイルス DNAリョウ ノ カイセキ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390853188956435840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Possible Therapeutic Applications of Targeting STAP Proteins in Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1570009750542664832","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma : Nuclear factor-κB pathway as a potential therapeutic target"}]},{"@id":"https://cir.nii.ac.jp/crid/1570572700495995392","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"γ-Herpesviruses and cellular signaling in AIDS-associated malignancies"}]},{"@id":"https://cir.nii.ac.jp/crid/1571698601161447552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"扁桃と Epstein-Barr virus (EBV) 感染"},{"@language":"en","@value":"EBV preferentially infects NALT-originating memory B cells at the portal of entry to establish viral persistence"}]},{"@id":"https://cir.nii.ac.jp/crid/1573950399761400448","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Dominant expression of survival signals of endoplasmic reticulum stress response in Hodgkin lymphoma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/35095584"},{"@type":"CIA","@value":"30014134187"},{"@type":"CROSSREF","@value":"10.1002/rmv.1786_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2021.639844_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.14789/pjmj.53.211_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.1248/bpb.b21-00672_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.1002/eji.201847886_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.1093/intimm/dxy053_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.18632/oncotarget.14120_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"},{"@type":"CROSSREF","@value":"10.1007/s11604-008-0291-2_references_DOI_J0g3w2AGdVeadkdvOoRWdzEQp42"}]}